BIOLIFE SOLUTIONS INC
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
BLFS$38.61+3.5%Stored close · as of Oct 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| Years Ended December 31 | |||
|---|---|---|---|
| (In thousands, except per share and share data) | 2025 | 2024 | 2023 |
| Revenue | $96,214 | $74,647 | $68,016 |
| Cost of revenue | 34,096 | 24,551 | 26,698 |
| Gross profit | 62,118 | 50,096 | 41,318 |
| Operating expenses: | |||
| General and administrative | 45,520 | 40,627 | 42,792 |
| Sales and marketing | 9,850 | 8,932 | 11,377 |
| Research and development | 7,566 | 4,751 | 5,515 |
| IPR&D expense | 15,521 | — | — |
| Intangible asset amortization | 263 | 263 | 1,032 |
| Change in fair value of contingent consideration | — | — | (2,193) |
| Total operating expenses | 78,720 | 54,573 | 58,523 |
| Operating loss | (16,602) | (4,477) | (17,205) |
| Other income (expense): | |||
| Interest income (expense), net | 2,706 | (766) | (1,406) |
| Other income | 1,815 | 494 | 1,275 |
| Change in fair value of investments | — | (4,074) | — |
| Gain on settlement of Global Cooling escrow | — | — | 5,115 |
| Total other income (expense), net | 4,521 | (4,346) | 4,984 |
| Loss from continuing operations before income tax expense (benefit) | (12,081) | (8,823) | (12,221) |
| Income tax expense (benefit) | 49 | (38) | (64) |
| Loss from continuing operations | (12,130) | (8,785) | (12,157) |
| Discontinued operations: | |||
| Income (loss) from discontinued operations before income tax expense | 7,535 | (11,267) | (55,612) |
| Income tax expense | — | 132 | 233 |
| Income (loss) from discontinued operations | 7,535 | (11,399) | (55,845) |
| Net loss | $(4,595) | $(20,184) | $(68,002) |
| Loss per share - Basic: | |||
| Continuing operations | $(0.25) | $(0.19) | $(0.28) |
| Discontinued operations | $0.16 | $(0.25) | $(1.27) |
| Net loss | $(0.09) | $(0.44) | $(1.55) |
| Loss per share - Diluted: | |||
| Continuing operations | $(0.25) | $(0.19) | $(0.28) |
| Discontinued operations | $0.15 | $(0.25) | $(1.27) |
| Net loss | $(0.10) | $(0.44) | $(1.55) |
| Weighted average shares used to compute net loss per share attributable to common shareholders: | |||
| Basic | 47,753,824 | 46,067,073 | 43,719,185 |
| Diluted | 48,645,084 | 46,067,073 | 43,719,185 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.